(3): 149–50. doi:10.1038/nrd4565. pmid 25722227. s2cid 2423838. lan, x; et, al (september 2017). "fate mapping of human glioblastoma reveals an invariant stem cell hierarchy". nature. 549 (7671): 227–232. bibcode:2017natur.549..227l. doi:10.1038/nature23666. pmc 5608080. pmid 28854171. kulandaimanuvel, am; et, al. (june 2020). "metabolic regulation of the epigenome drives lethal infantile ependymoma". cell. 181 (6): 1329–1345.e24. doi:10.1016/j.cell.2020.04.047. pmid 32445698. s2cid 218842162. open science muller, s; et, al. (april 2018). "donated chemical probes for open science". elife. 7. doi:10.7554/elife.34311. pmc 5910019. pmid 29676732. s2cid 4976020. harding, rj (january 2019). "open notebook science can maximize impact for rare disease projects". plos biol. 17 (1): e3000120. doi:10.1371/journal.pbio.3000120. pmc 6366684. pmid 30689629. s2cid 59338390. reproducibility frye, sv; arkin, mr; arrowsmith, ch; conn, pj; glicksman, ma; hull-ryde, ea; slusher, bs (november 2015). "tackling reproducibility in academic preclinical drug discovery". nature reviews drug discovery. 14 (11): 733–4. doi:10.1038/nrd4737. pmid 26388229. s2cid 205478934. marcon, e; et, al. (august 2015). "assessment of a method to characterize antibody selectivity and specificity for use in immunoprecipitation". nature methods. 12 (8): 725–31. doi:10.1038/nmeth.3472. pmid 26121405. s2cid 205423964. laflamme, c; et, al. (october 2019). "implementation of an antibody characterization procedure and application to the major als/ftd disease gene c9orf72". elife. 8. doi:10.7554/elife.48363. pmc 6794092. pmid 31612854. s2cid 204704632.